Protocol Summaries: GSK1247303
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| IGZ111452 | Phase 1 | A Double-Blind, Parallel, Randomized, Placebo-Controlled, Single and Repeat Dose Escalation First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1247303 in Healthy Male and Female Subjects | Terminated |